Isomorphic lands deals with Lilly, Novartis worth nearly $3B

Just more than two years after launching within Alphabet, Isomorphic has inked two large pharma deals with Eli Lilly and Novartis with nearly $3 billion in combined deal value.  | Just more than two years after launching within Alphabet, Isomorphic has inked two large pharma deals with Eli Lilly and Novartis with nearly $3 billion in combined deal value. 

Michael Jackson on LinkedIn: #technology #tech #innovation #science #deeptech #ai…

AI and Machine Learning

Google's AI Spin-Off Isomorphic Labs Strikes Big Pharma Deals, Paving the Way for Future of Drug Discovery - Alphabet (NASDAQ:GOOG), Alphabet (NASDAQ:GOOGL), Eli Lilly (NYSE:LLY), Novartis (NYSE:NVS) - Benzinga

Michael Jackson on LinkedIn: New £1 billion strategy for UK's semiconductor sector

Fierce Biotech News & Reports

Steve Harvey on LinkedIn: Zoom interview tips

Max Bayer Fierce JPM Week

Michael Jackson on LinkedIn: #techbbq #tech #technology #innovation #deeptech #vc #venturecapital…

MedTech News - Medical Innovation Exchange